Multidisciplinary consensus: A practical guide for the integration of abiraterone into clinical practice
Henry H Woo, Stephen Begbie, Kumar Gogna, Paul N Mainwaring, Declan G Murphy, Francis Parnis, Christopher Steer, Ian D Davis
Asia-Pacific Journal of Clinical Oncology | WILEY | Published : 2014
Abiraterone improves survival, relieves pain, improves quality of life and extends time to prostate-specific antigen (PSA) progression in patients with metastatic castration-resistant prostate cancer (mCRPC). A consensus-based guide for using abiraterone in patients with mCRPC has been developed by Australian clinicians with expertise in prostate cancer, based on their experience and supported by published data. Recommendations were developed for eight key topics: abiraterone administration; steroid administration and duration of use; concomitant medications and drug interactions; timing of testing and monitoring response; safety in different populations; potential toxicities; precautions an..View full abstract
Medical writing and administrative support was provided by Dr Anja Becher and Ms Donna Bartlett from Allori. Funding support for meetings, administrative assistance and medical writing support were funded by Janssen Australia. Janssen did not influence the content or development of the manuscript.